Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,505Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Merck Canada Inc.

02 1Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2305803

Filing Date : 1998-10-05

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-05

Date Granted : 2009-12-22

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2443089

Filing Date : 2002-04-01

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-04-01

Date Granted : 2011-11-01

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

blank

05

arrow
Peptide Process CMC
Not Confirmed

Country
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 300 mg / vial (18 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

blank

06

Merck Canada Inc.

arrow
Peptide Process CMC
Not Confirmed

Merck Canada Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2865950

Filing Date : 2013-02-27

Strength per Unit : 300 mg / vial (18 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-02-27

Date Granted : 2016-12-20

blank

07

Merck Canada Inc.

arrow
Peptide Process CMC
Not Confirmed

Merck Canada Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Posaconazole

Brand Name : POSANOL

Patent Number : 2802929

Filing Date : 2011-06-24

Strength per Unit : 300 mg / vial (18 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2031-06-24

Date Granted : 2019-01-08

blank